BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 29
• 30
• 31

• Biotech Beach

  BIOLASE Technology, Inc. to Present at Upcoming Investment Conferences in New York City

  May 30, 2007

   · 

  1 min read
• Policy

  US Court Continues to Prevent Teva Pharmaceutical Industries Limited From Shipping Any Additional Generic Copies of the High Blood Pressure Medicine Lotrel

  May 30, 2007

   · 

  1 min read
• Business

  Stem Cell Therapeutics Announces First Quarter 2007 Financial Results

  May 30, 2007

   · 

  1 min read
• Business

  BioDuro, LLC Announces Appointment of Nigel R. A. Beeley, Ph.D., as CEO, China Operations

  May 30, 2007

   · 

  3 min read
• Policy

  Wex Pharmaceuticals Inc.: Tianjin’s Response to the Legal Proceedings

  May 30, 2007

   · 

  1 min read
• BioCapital

  MaxCyte, Inc. to Present at American Society for Gene Therapy 10th Annual Meeting

  May 30, 2007

   · 

  1 min read
• Policy

  MedPointe Pharmaceuticals Settles Litigation with Hi-Tech Pharmacal and Successfully Enforces Patent Covering its Tussi-12(R) D Products

  May 30, 2007

   · 

  1 min read
• Business

  BioWa and Takeda Pharmaceutical Co. Ltd. Announce Licensing of BioWa’s POTELLIGENT(R) Technology for Use in Antibody Research and Development

  May 30, 2007

   · 

  3 min read
• Policy

  Symbollon Pharmaceuticals Receives Regulatory Guidance From the United Kingdom

  May 30, 2007

   · 

  1 min read
• Drug Development

  Exelixis, Inc. Initiates Phase II Trial of XL647 in NSCLC Patients Who Have Previously Benefited From EGFR Inhibitors or Have the T790M Mutant Form of EGFR

  May 30, 2007

   · 

  4 min read